On 7 July 2026 the Upper Tribunal (Tax and Chancery Chamber) held that clear aligners are not “dental prostheses”, and are therefore standard-rated for VAT rather than exempt. The decision is HM Revenue and Customs v Align Technology Switzerland GmbH [2026] UKUT 00256 (TCC), heard on 7 May before Mr Justice Edwin Johnson and Judge Jeanette Zaman.

Most of what circulated in the trade press through August was second-hand, and the hedging varied with the source. The judgment itself is public, it is 22 pages, and it settles several questions the coverage left open. This is what it says, what it does not touch, and where the cost actually lands.

What the Tribunal decided

Align treated its supplies of Invisalign aligners as exempt supplies of dental prostheses. HMRC decided they were standard-rated. Align appealed and won at the First-tier Tribunal in 2025; HMRC was granted permission to appeal on a single ground, that the FTT had misinterpreted the phrase “dental prostheses”.

The Upper Tribunal agreed with HMRC. Its conclusion, at paragraph 96:

“[W]e have concluded that ‘dental prostheses’, as used in the Exemption, means artificial items which replace missing or damaged teeth. They do not include the Aligners. The FTT therefore made an error of law…”

Two things follow from how it disposed of the case, and both matter more than the coverage suggested. The Tribunal did not send the case back to the First-tier Tribunal to be decided again: it found the error material, set the FTT’s decision aside, and — since Align accepted there was no remaining question of fact if HMRC’s definition was accepted — re-made the decision itself. At paragraph 101: “HMRC’s appeal against the FTT Decision is allowed. We set aside the FTT Decision and remake it to dismiss Align’s appeal against the decision of HMRC that the Aligners are chargeable to VAT.”

So there is no rehearing pending, and no live first-instance decision saying aligners are exempt. That is the state of play as of today.

Why “dental” did not widen the meaning

The exemption is Items 2 and 2A of Group 7, Schedule 9 to the Value Added Tax Act 1994, which the judgment sets out at paragraph 5. Item 2 exempts “the supply of any services consisting in the provision of medical care, or the supply of dental prostheses” by a person on the dentists’ register or the dental care professionals register. Item 2A exempts “the supply of any services or dental prostheses by a dental technician.”

The argument was about four words, and the Tribunal worked outward from the ordinary meaning of “prosthesis” — an artificial replacement for a part of the body — to ask whether adding “dental” stretched it to cover an appliance that moves teeth already present. It held not (paragraph 63): the addition of “dental” “appears, at least at first sight, simply to mean that the prostheses which are referred to in the Exemption are those which operate in relation to teeth.”

Align’s strongest material was lexical, and the Tribunal dealt with it candidly. The dictionaries, it noted at paragraph 64, “do not speak with one voice”: the Oxford Dictionary of Dentistry and Taber’s list orthodontic appliances and retainers among dental prostheses, while Black’s, Mosby’s and Stedman’s define the term by replacement. That gave “some, but only limited, support” for Align’s reading — not enough to displace the ordinary meaning, read alongside Article 132(1)(e) of the Principal VAT Directive, which the exemption implements, and EU VAT Committee material the Tribunal held it was entitled to take into account.

Worth keeping straight, because it was blurred in August: this is statutory construction, not a clinical judgment. Nothing in the decision says aligner treatment is ineffective or unnecessary, and the FTT’s findings of fact — unchallenged on appeal — describe aligners as “removable orthodontic appliances used by dental professionals to treat malocclusion in patients by repositioning their teeth”, worn 20 to 22 hours a day. The Tribunal decided what a word in a tax statute means. It did not grade the treatment.

What the ruling does not touch

Your clinical fees are unaffected. The medical-care limb of Item 2 is a separate limb of the same item, and the Tribunal construed only the phrase “dental prostheses”. A registered dentist or dental care professional assessing a patient, planning treatment, fitting and reviewing an appliance is supplying medical care, and that supply remains exempt.

Nor does it disturb the things that plainly do replace teeth. On the Tribunal’s own definition — artificial items which replace missing or damaged teeth — crowns, bridges and dentures sit squarely inside the exemption. HMRC’s published guidance for dentists, VATHLT2490, lists exactly that sort of item: dentures, bridges, crowns and inlays, obturators, splints, palates and individual artificial teeth. Note what is absent, and has always been absent: the page does not mention orthodontic appliances or aligners at all, and it was last updated on 31 July 2023 — before any of this. Read it as unchanged guidance consistent with the ruling, not as guidance issued in response to it.

Is it settled?

Settled enough to plan around, with one caveat named precisely.

Because the Upper Tribunal re-made the decision rather than remitting it, nothing further happens unless Align takes it up to the Court of Appeal, which needs permission. The judgment records no such application — it would not, at that stage — and we have found no Revenue and Customs Brief or other HMRC statement on aligners published since the decision. Two things are worth watching, and only these two: a Court of Appeal listing, and an HMRC brief or an update to VATHLT2490. Everything else circulating is commentary.

What that means practically: the position for supplies now is clear, while questions about past periods — how far back HMRC assesses, and on whom — are not answered by this judgment and are a matter for your own adviser on your own facts. We are not going to model them for you from a judgment that does not address them.

Why the cost lands on practices, not on Align

The mechanic is the same one that makes every input cost bite in this sector, and it is worth stating plainly because it is what makes a supplier’s tax case your problem.

Because most of what a practice supplies to patients is VAT-exempt, most practices cannot recover the VAT they are charged on what they buy. A standard-rated appliance is therefore not a pass-through: the 20% is an irrecoverable cost of delivering the treatment, sitting on your margin unless you put fees up. That is why a ruling about a manufacturer’s supplies shows up in your lab bill rather than in Align’s results.

The British Orthodontic Society made that argument to government. In an open letter dated 3 August 2026 to the health secretary, signed by its director for clinical practice Matt Clover, the BOS called on ministers to work with HM Treasury, HMRC and the devolved administrations to assess the impact and to introduce a clear exemption for prescribed orthodontic appliances and other clinically necessary, patient-specific devices; Clover said he had coordinated with the British Dental Association, the Dental Laboratories Association and appliance and aligner providers. We have not seen the letter itself — it reaches us through GDPUK and The Probe, both of which reported it on 4 August. Treat it as what it is: a representative body’s position, reported at second hand, not a change in the law. Nothing has changed in the legislation since.

What this means for your practice

Ask each supplying lab, in writing, how it is treating VAT on aligners and from what date — that letter is the document your accountant will want, and the answer may differ between labs. Ask your accountant two questions specific to you: whether your recovery position changes, and how staged patient payments are treated. Then, and only then, decide on fees. If you do reprice, price the change as what it is — a supplier cost driven by a tax ruling. Do not touch patient-facing claims: if any of your copy describes aligners or retainers as “replacing” anything, correct it, because it is now conspicuously wrong in the tax sense and was never right clinically.

Keep it out of your marketing

One warning on communications. If lab costs rise and you adjust fees, explain it plainly as a supplier-cost change. Do not dress a price rise up as a clinical upgrade or “premium service”, which risks a misleading-pricing problem under the CAP Code and GDC advertising guidance. And do not lift Align’s litigation language about the health benefits of aligners into website copy as though it were established fact: those were submissions made to win a tax argument, and they lost. This is a story for your accountant and your treatment coordinators to manage quietly, not a marketing angle.